Here we present a new model for alveolar jaw bone regeneration, which uses human dental pulp cells (hDPCs) combined with tyrosine-derived polycarbonate polymer scaffolds [E1001(1k)] containing beta-tricalcium phosphate (β-TCP) [E1001(1k)/β-TCP]. E1001(1k)/β-TCP scaffolds (5 mm diameter × 1 mm thickness) were fabricated to fit a 5 mm rat mandibular ramus critical bone defect. Five experimental groups were examined in this study: (1) E1001(1k)/β-TCP scaffolds seeded with a high density of hDPCs, 5.0 × 105 hDPCs/scaffold (CH); (2) E1001(1k)/β-TCP scaffolds seeded with a lower density of hDPCs, 2.5 × 105 hDPCs/scaffold (CL); (3) acellular E1001(1k)/β-TCP scaffolds (SA); (4) acellular E1001(1k)/β-TCP scaffolds supplemented with 4 μg recombinant human bone morphogenetic protein-2 (BMP); and (5) empty defects (EDs). Replicate hDPC-seeded and acellular E1001(1k)/β-TCP scaffolds were cultured in vitro in osteogenic media for 1 week before implantation for 3 and 6 weeks. Live microcomputed tomography (μCT) imaging at 3 and 6 weeks postimplantation revealed robust bone regeneration in the BMP implant group. CH and CL groups exhibited similar uniformly distributed mineralized tissue coverage throughout the defects, but less than the BMP implants. In contrast, SA-treated defects exhibited sparse areas of mineralized tissue regeneration. The ED group exhibited slightly reduced defect size. Histological analyses revealed no indication of an immune response. In addition, robust expression of dentin and bone differentiation marker expression was observed in hDPC-seeded scaffolds, whereas, in contrast, BMP and SA implants exhibited only bone and not dentin differentiation marker expression. hDPCs were detected in 3-week but not in 6-week hDPC-seeded scaffold groups, indicating their survival for at least 3 weeks. Together, these results show that hDPC-seeded E1001(1k)/β-TCP scaffolds support the rapid regeneration of osteo-dentin-like mineralized jaw tissue, suggesting a promising new therapy for alveolar jaw bone repair and regeneration.
Get full access to this article
View all access options for this article.
References
1.
DavisR.E., and TelischiF.F.Traumatic facial nerve injuries: review of diagnosis and treatment. J Craniomaxillofac Trauma, 1, 30, 1995.
2.
CurtisD.A., PleshO., MillerA.J., CurtisT.A., SharmaA., SchweitzerR., HilsingerR.L., SchourL., and SingerM.A comparison of masticatory function in patients with or without reconstruction of the mandible. Head Neck, 19, 287, 1997.
3.
LaineJ., VahataloK., PeltolaJ., TammisaloT., and HapponenR.P.Rehabilitation of patients with congenital unrepaired cleft palate defects using free iliac crest bone grafts and dental implants. Int J Oral Maxillofac Implants, 17, 573, 2002.
4.
CoulthardP., EspositoM., JokstadA., and WorthingtonH.V.Interventions for replacing missing teeth: bone augmentation techniques for dental implant treatment. Cochrane Database Syst Rev, CD003607, 2003.
5.
DimitriouR., JonesE., McGonagleD., and GiannoudisP.V.Bone regeneration: current concepts and future directions. BMC Med, 9, 66, 2011.
6.
OppenheimerA.J., TongL., and BuchmanS.R.Craniofacial bone grafting: Wolff's law revisited. Craniomaxillofac Trauma Reconstr, 1, 49, 2008.
7.
ChaiY., and MaxsonR.E.Jr. Recent advances in craniofacial morphogenesis. Dev Dyn, 235, 2353, 2006.
8.
AghalooT.L., ChaichanasakulT., BezouglaiaO., KangB., FrancoR., DryS.M., AttiE., and TetradisS.Osteogenic potential of mandibular vs. long-bone marrow stromal cells. J Dent Res, 89, 1293, 2010.
9.
PagniG., KaiglerD., RasperiniG., Avila-OrtizG., BartelR., and GiannobileW.V.Bone repair cells for craniofacial regeneration. Adv Drug Deliv Rev, 64, 1310, 2012.
10.
KaiglerD., PagniG., ParkC.H., TarleS.A., BartelR.L., and GiannobileW.V.Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration. Tissue Eng Part A, 16, 2809, 2010.
11.
RobeyP.G., KuznetsovS.A., RenJ., KleinH.G., SabatinoM., and StroncekD.F.Generation of clinical grade human bone marrow stromal cells for use in bone regeneration. Bone, 70, 87, 2015.
12.
SoltanM., SmilerD., PrasadH.S., and RohrerM.D.Bone block allograft impregnated with bone marrow aspirate. Implant Dent, 16, 329, 2007.
13.
TobitaM., UysalA.C., OgawaR., HyakusokuH., and MizunoH.Periodontal tissue regeneration with adipose-derived stem cells. Tissue Eng Part A, 14, 945, 2008.
14.
JinQ.M., AnusaksathienO., WebbS.A., RutherfordR.B., and GiannobileW.V.Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol, 74, 202, 2003.
15.
IoharaK., ZhengL., ItoM., TomokiyoA., MatsushitaK., and NakashimaM.Side population cells isolated from porcine dental pulp tissue with self-renewal and multipotency for dentinogenesis, chondrogenesis, adipogenesis, and neurogenesis. Stem Cells, 24, 2493, 2006.
16.
ZhangW., WalboomersX.F., van KuppeveltT.H., DaamenW.F., BianZ., and JansenJ.A.The performance of human dental pulp stem cells on different three-dimensional scaffold materials. Biomaterials, 27, 5658, 2006.
17.
ZhangW., WalboomersX.F., van OschG.J., van den DolderJ., and JansenJ.A.Hard tissue formation in a porous HA/TCP ceramic scaffold loaded with stromal cells derived from dental pulp and bone marrow. Tissue Eng Part A, 14, 285, 2008.
18.
YoungC.S., TeradaS., VacantiJ.P., HondaM., BartlettJ.D., and YelickP.C.Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res, 81, 695, 2002.
19.
AbukawaH., ZhangW., YoungC.S., AsricanR., VacantiJ.P., KabanL.B., TroulisM.J., and YelickP.C.Reconstructing mandibular defects using autologous tissue-engineered tooth and bone constructs. J Oral Maxillofac Surg, 67, 335, 2009.
BourkeS.L., and KohnJ.Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliv Rev, 55, 447, 2003.
22.
PulapuraS., and KohnJ.Tyrosine-derived polycarbonates: backbone-modified “pseudo”-poly (amino acids) designed for biomedical applications. Biopolymers, 32, 411, 1992.
23.
MagnoM.H.R., KimJ., SrinivasanA., McBrideS., BolikalD., DarrA., HollingerJ.O., and KohnJ.Synthesis, degradation and biocompatibility of tyrosine-derived polycarbonate scaffolds. J Mater Chem, 20, 8885, 2010.
24.
KimJ., MagnoM.H., AlvarezP., DarrA., KohnJ., and HollingerJ.O.Osteogenic differentiation of pre-osteoblasts on biomimetic tyrosine-derived polycarbonate scaffolds. Biomacromolecules, 12, 3520, 2011.
25.
KimJ., MagnoM.H., WatersH., DollB.A., McBrideS., AlvarezP., DarrA., VasanjiA., KohnJ., and HollingerJ.O.Bone regeneration in a rabbit critical-sized calvarial model using tyrosine-derived polycarbonate scaffolds. Tissue Eng Part A, 18, 1132, 2012.
26.
GudaT., DarrA., SillimanD.T., MagnoM.H., WenkeJ.C., KohnJ., and Brown BaerP.R.Methods to analyze bone regenerative response to different rhBMP-2 doses in rabbit craniofacial defects. Tissue Eng Part C Methods, 20, 749, 2014.
27.
KimJ., McBrideS., DonovanA., DarrA., MagnoM.H., and HollingerJ.O.Tyrosine-derived polycarbonate scaffolds for bone regeneration in a rabbit radius critical-size defect model. Biomed Mater, 10, 035001, 2015.
28.
ZhangW., AhluwaliaI.P., LitermanR., KaplanD.L., and YelickP.C.Human dental pulp progenitor cell behavior on aqueous and hexafluoroisopropanol based silk scaffolds. J Biomed Mater Res A, 97, 414, 2011.
29.
KabanL.B., and GlowackiJ.Induced osteogenesis in the repair of experimental mandibular defects in rats. J Dent Res, 60, 1356, 1981.
30.
XiaoY., HaaseH., YoungW.G., and BartoldP.M.Development and transplantation of a mineralized matrix formed by osteoblasts in vitro for bone regeneration. Cell Transplant, 13, 15, 2004.
31.
MalicevE., MaroltD., Kregar VelikonjaN., KreftM.E., DrobnicM., and RodeM.Growth and differentiation of alveolar bone cells in tissue-engineered constructs and monolayer cultures. Biotechnol Bioeng, 100, 773, 2008.
32.
ChenS., Gluhak-HeinrichJ., WangY.H., WuY.M., ChuangH.H., ChenL., YuanG.H., DongJ., GayI., and MacDougallM.Runx2, osx, and dspp in tooth development. J Dent Res, 88, 904, 2009.
33.
ChenY., ZhangY., RamachandranA., and GeorgeA.DSPP is essential for normal development of the dental-craniofacial complex. J Dent Res, 95, 302, 2016.
34.
AminiA.R., LaurencinC.T., and NukavarapuS.P.Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng, 40, 363, 2012.
35.
GroeneveldE.H., van den BerghJ.P., HolzmannP., ten BruggenkateC.M., TuinzingD.B., and BurgerE.H.Mineralization processes in demineralized bone matrix grafts in human maxillary sinus floor elevations. J Biomed Mater Res, 48, 393, 1999.
36.
YangS., LeongK.F., DuZ., and ChuaC.K.The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng, 7, 679, 2001.
37.
PopovV.K., EvseevA.V., IvanovA.L., RoginskiV.V., VolozhinA.I., and HowdleS.M.Laser stereolithography and supercritical fluid processing for custom-designed implant fabrication. J Mater Sci Mater Med, 15, 123, 2004.
38.
AntonovE.N., BagratashviliV.N., WhitakerM.J., BarryJ.J., ShakesheffK.M., KonovalovA.N., PopovV.K., and HowdleS.M.Three-dimensional bioactive and biodegradable scaffolds fabricated by surface-selective laser sintering. Adv Mater, 17, 327, 2004.
39.
KuttenbergerJ.J., and HardtN.Long-term results following reconstruction of craniofacial defects with titanium micro-mesh systems. J Maxillofac Surg, 29, 75, 2001.
40.
ScholzM., EufingerH., WehmollerM., HeuserL., and HardersA.CAD/CAM (computer-aided design/computer-aided manufacturing) titanium implants for cranial and craniofacial defect reconstruction. Zentralbl Neurochir, 58, 105, 1997.
41.
HoS., NallathambyV., NgH., HoM., and WongM.A novel application of calcium phosphate-based bone cement as an adjunct procedure in adult craniofacial reconstruction. Craniomaxillofac Trauma Reconstr, 4, 235, 2011.
42.
CohenS.R., HolmesR.E., MeltzerH.S., LevyM.L., and BeckettM.Z.Craniofacial reconstruction with a fast resorbing polymer: a 6- to 12-month clinical follow-up review. Neurosurg Focus, 16, E12, 2004.
43.
HutmacherD.W.Scaffolds in tissue engineering bone and cartilage. Biomaterials, 21, 2529, 2000.
44.
SaizE., ZimmermannE.A., LeeJ.S., WegstU.G., and TomsiaA.P.Perspectives on the role of nanotechnology in bone tissue engineering. Dent Mater, 29, 103, 2013.
45.
DupontK.M., SharmaK., StevensH.Y., BoerckelJ.D., GarciaA.J., and GuldbergR.E.Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci U S A, 107, 3305, 2010.
46.
WozneyJ.M., RosenV., CelesteA.J., MitsockL.M., WhittersM.J., KrizR.W., HewickR.M., and WangE.A.Novel regulators of bone formation: molecular clones and activities. Science, 242, 1528, 1988.
47.
RileyE.H., LaneJ.M., UristM.R., LyonsK.M., and LiebermanJ.R. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res, 39, 1996.
48.
OngK.L., VillarragaM.L., LauE., CarreonL.Y., KurtzS.M., and GlassmanS.D.Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976), 35, 1794, 2010.
49.
ChenardK.E., TevenC.M., HeT.C., and ReidR.R.Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy. J Biomed Biotechnol, 2012, 601549, 2012.
50.
ParkJ., RiesJ., GelseK., KlossF., von der MarkK., WiltfangJ., NeukamF.W., and SchneiderH.Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther, 10, 1089, 2003.
51.
KabanL.B., GlowackiJ., and MurrayJ.E.Repair of experimental mandibular bony defects in rats. Surg Forum, 30, 519, 1979.
52.
SchmitzJ.P., and HollingerJ.O.The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res, 299, 1986.
53.
HiguchiT., KinoshitaA., TakahashiK., OdaS., and IshikawaI.Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol, 70, 1026, 1999.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
